Erythropoietin in of patients cancer with anemia;Erythropoietine chez des patients cancereux anemiques

Tunisie Medicale

Volumn 85, Issue 2, 2007, Pages 131-133

  Gara, Sonia ^a   Ghanem, Abdelraouf ^a   Jmal, Awatef ^a   Loussaïef, Wafa ^a   Gara, Yosr ^a   Baaboura, Rekaya ^a   Mtaallah, Habib ^a   Harzallah, Latifa ^a   Abbes, Salem ^b   Abdennebi, Monia ^a   Guemira, Fethi ^a  

^a SALAH AZAIEZ INSTITUTE   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Anemia; Cancer; Erythropoietin

Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN; FERRITIN; RECOMBINANT ERYTHROPOIETIN;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BLOOD SAMPLING; CANCER; CLINICAL FEATURE; CONTROLLED STUDY; FERRITIN BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MICROCYTIC ANEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CASE-CONTROL STUDIES; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES;

EID: 34248545222     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Littlewood TJ, Bajetta E, Nortier JWR, et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy : Results of a randomised, double blind, placebo-controlled trial. J Clin Oncol 2001;19 :2865-74.
2. Bron D, Meuleman N, Mascaux C. Biological basis of anemia. Seminars in oncology 2001;28:1-6.
3. Miller CB, Jones RJ, Piantadosi S, et al. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990;322:1689-1692.
4. Bondurant MC, Koury MJ. Anemia induces accumulation of erythropoietin mRNA in hte kidney and the liver. Mol Cell Biol 1986;6:2731-3.
5. Koury ST, Boudurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells.Science 1990 ;248 :378-81.
6. Lacombe C, Mayeux P, Casadevall N. Le point sur l'érythropoï étine. Néphrologie 1991 ;12 :221-6
7. Hoynck van Papendrecht MA,Jeekel H, Busch OR, Marquet RL.Efficacy of recombinant erythropoietin for stimulating erythropoiesis after blood loss and surgery. An experimental study in rats. Eur J Surg 1992 ;158 :83-7.
8. Krafte-Jacobs B, Levetown ML, Bray GL, Ruttimann UE, Pollack MM. Erythropoietin response to critical illness. Crit Care Med 1994;22 :821-6.
9. Chudek J, Wiecek A, Kokot F, Grochal A, Switala J, Kanwiszer J.Serum erythropoietin cocentration in women with uterine or ovarian tumors. Przegl Lek 1998 ;55 :47-50.
10. Lapa K, Kokot F, Oklek K, Cieslicki J, Machalski M, Chudek J, Wiecek A. Plasma erythropoietin concentration in lung cancers patients. Pneumonol Alergol Pol 2002 ;70 :243-50.
11. Rokicka-Piotrowicz M, Paszkowska M, Krol M, Krol M, Kuratowska Z. Analysis of causes for anemia in patients with multiple myeloma. Pol Arch Med Wewn 2000 ;104 :843-51.
12. Barosi G. Inadequate erythropoietin response to anemia : definition and clinicalrelevance.Ann Hematol 1994 ;68 :215-23.
13. Morant R,Bacchus L, Meyer J, Riesen WF. Tumor-induced anemia and markers of inflammation. Schweiz Med Wochenschr 1994 ;124 :2267-71.
14. Frede S, Fandrey J, Pagel H,Hellwig T, Jelkmann W. Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1 beta injections in rats. Am J Physiol 1997 ;273 :R1067-71.
15. Weiss G. Pathogenesis and treatment of anemia of chronic disease. Blood Rev 2002 ;16 :87-96.
16. Jelkmann WE, Fandrey J, Frede S, Pagel H. Inhibition of erythropoietin production by cytokines. Implications for anemia involved in inflammatory states. Ann NY Acad Sci 1994 ;718 :300-11.
17. Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T, Heinrich PC. Induction of rate acute-phase proteins by interleukine 6 in vivo. Eur J Immunol 1988 ;18 :717-21.
18. Ulish TR, Del Castillo J, Yin SM, Egrie JC. The erythropoietic effects of interleukine 6 and erythropoietin in vivo. Exp Hematol 1991 ;19 :29-34.
19. Van Iperen CE, Biesma DH, Van de Wiel A, Marx JJM. Erythropoietic response to acute aneamia and chronic aneamia : focus on postoperative anaemia. Br Aneasth 1998 ;81 :2-5.
20. Littlewood TJ. The impact of hemoglobin levels on treatment outcomes in patients with cancer. Demin Oncol 2001 ;28: 49-53.
21. Marchal C, Rangeard L, Brunaud C. Anemia impact on traitements of cervical carcinomas. Cancer/Radiotherapie 2005; 9: 87-95.